Neubourg skin care GmbH is based in Greven and specialises in the distribution of dermatological healthcare products in the skin and foot care segment. As of June 30, 2024, the company was part of the neubourg group and since February 2024 a 100% subsidiary of AVIA Pharma Germany GmbH. In the 2023/24 financial year the company generated revenue of 12,071 TEUR and employed on average 46 staff. Key brands are Allpresan® (82% share of domestic sales) and Onyfix®, and the company holds 100% stakes in Sixtus GmbH and nsc pharma GmbH & Co. KG. The company is a small company under § 267 (1) HGB and is therefore not required to publish a profit-and-loss statement.
Der Vertrieb von Gesundheitsprodukten.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Steinfurt Local Court, HRB 6129 (as of 1 November 2026)
| Name | Type | City |
|---|---|---|
| Stefan Lang | Geschäftsführer(in) | München |
Source: German Commercial Register (Handelsregister) Steinfurt Local Court, HRB 6129 (as of 1 November 2026)
| Date | Event Type | Event |
|---|---|---|
| 01.08.2024 | Gesellschaftsvertrag amended | Gesellschaftsvertrag |
| 23.02.2024 | Gesellschaftsvertrag amended | Gesellschaftsvertrag |
| 16.10.2018 | Company Name Change | neubourg skin care GmbH |
| Date | Type | Change | Total Capital |
|---|---|---|---|
| 16.10.2018 | Capital Increase | +1.400.000 € | 1.425.000 € |
| 16.08.2004 | Share Capital Set | — | 25.000 € |
Source: German Commercial Register (Handelsregister) Steinfurt Local Court, HRB 6129 (as of 1 November 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2025 | small company1 | — | €5,999,456 | — |
| 2024 | Rohergebnis€9.5M2 | -€3,337,793 | €5,855,296 | — |
| 2023 | Rohergebnis€9.5M2 | €11,966 | €10,029,803 | — |
| 2022 | Rohergebnis€10.3M2 | €203,174 | €10,305,129 | — |
| 2021 | small company1 | — | €5,534,721 | — |
| 2020 | small company1 | — | €5,984,700 | — |
| 2019 | small company1 | — | €5,163,040 | — |
| 2018 | — | — | €44,746 | — |
| 2015 | small company1 | — | €44,191 | — |
| 2014 | small company1 | — | €43,688 | — |
1 Small companies are not required to publish a profit-and-loss statement (§ 326 (1) HGB). The figure shown is the statutory ceiling under § 267 HGB where the balance-sheet total makes it binding — a company may exceed at most one of the three size criteria.
2 Rohergebnis nach § 276 HGB: Umsatzerlöse abzüglich Materialaufwand bzw. Herstellungskosten. Kleine und mittelgroße Kapitalgesellschaften dürfen diese Posten zusammenfassen; die Umsatzerlöse selbst sind dann nicht veröffentlicht und liegen über dem Rohergebnis.
Sign in to download data
Source: German Commercial Register (Handelsregister) Steinfurt Local Court, HRB 6129 (as of 1 November 2026)
SC Sanitätshaus Carstens GmbH
Stuttgart · Einzelhandel mit sonstigen medizinischen und orthopädischen Artikeln
SPRINGER AKTIV AG
Berlin · Einzelhandel mit sonstigen medizinischen und orthopädischen Artikeln
1001 Artikel Medical GmbH
Großenhain · Einzelhandel mit sonstigen medizinischen und orthopädischen Artikeln
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €2,853,373 | 38.7% |
| Depreciation | €4,358,767 | 59.0% |
| Interest & Similar | €169,653 | 2.3% |
